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Crohn’s Disease: An Evolutionary History
 BY THOMAS MICHNIACKI 
Introduction
Crohn’s disease is classified as an Inflammatory Bowel Disease. The disease is capable of causing severe 
inflammation in any portion of an individual’s gastrointestinal tract and is often chronic in nature. The 
symptoms of Crohn’s disease arise due to complex interactions between genes, the environment, and the 
patient’s immune system. An initial trigger in the patient’s gastrointestinal mucosa begins the complex 
process of inflammation involved in Crohn’s disease. 
Once the activation of immunity has begun, the body fails in its attempts to control the immune response 
and excessive inflammation occurs. This exacerbated inflammation is due to excess Th1 cytokine produc-
tion and often inadequate Th2 cytokine creation. Th1 and Th2 cells are two types of lymphocyte subpopula-
tions that secrete proteins (e.g. cytokines) that help regulate immune responses. 
Having disproportionate levels of Th1 and Th2 cytokines is especially debilitating because Th1 cytokines 
are the driving force in fighting infections in the mucosa membrane. Without enough Th2 cytokines (the 
inhibitory cytokines) to inform the Th1 cytokines to cease attacking, excess inflammation and severe dam-
age occur.1 This imbalance of Th1 and Th2 cytokine production has led many to believe that Crohn’s disease 
is an autoimmune disease. An autoimmune disease is characterized by the targeted destruction of self-tis-
sue by the immune system.2
 
The complexities of Crohn’s disease lie within the affected individual’s genes. Multiple gene mutations (po-
tentially more than 8) cause the many mechanisms present in Crohn’s disease.3 Abnormalities arising on 
the NOD2, Vitamin D receptor, and Th-2 cytokine production genes may hold the key to unraveling the 
complexities of this disorder.4 These complex mutations could potentially interact with environmental fac-
tors to create toleration or possibly even selection for the genes that cause vulnerability to Crohn’s disease.
Environmental Influence
The evolutionary history of Crohn’s disease begins in Africa with a few chance gene mutations. The first 
important mutations arise on the NOD2 (CARD 15) gene and genes involving Th1 and Th2 cytokine 
creation.3 The NOD2 gene is similar to a gene that creates bacteria resistant proteins in plants.4 With the 
development of the NOD2 mutation, those carrying the alteration now have an increased vulnerability to 
contracting a bacterial infection in their gastrointestinal mucosa. However, the excess inflammation that 
is characteristic of Crohn’s disease may not arise in individuals that carry the genetic material alterations 
because of factors present in the African environment. Helminthic worms and parasites are rampant in the 
environment and individuals are prone to contracting them.5 In individuals that have the NOD2 mutation, 
the contraction of the Helminthic worms may have beneficial aspects.
Studies have shown that infection with Helminthic worms may lead to elevation of the Th2 cytokine levels 
in patients.5 An elevation of Th2 cytokines would potentially offset the harmful qualities of having excess 
Th1 cytokines that continually attack an area of the gastrointestinal tract. An individual could potentially 
carry some of the genetic mutations that lead to Crohn’s disease but not show the damaging excess inflam-
mation of the disease because the Helminthic worms that lie within the patient’s body balance out the 








defenses.  Parasites may modify the bodily defense system of individuals afflicted with Crohn’s disease and thus 
cause the genetic mutations that lead to Crohn’s disease to be tolerated in an early evolutionary environment with 
a plentiful supply of Helminthic worms. This hypothesis may prove to be falsified with further research into the 
potential benefits of Helminthic worms and other parasites but the potential of having no selection for or against 
the mutations because no Crohn’s phenotype is manifested in this early environment is fascinating. 
Early human evolutionary history took place in surroundings similar to the tropics of today. A great deal of sun-
light (and thus Vitamin D) is present in both the tropics of today and the early evolutionary environment of hu-
mans. Interestingly, Crohn’s disease is very uncommon in the tropics today.6 Vitamin D may hold the key to the 
toleration of gene mutations found in individuals with Crohn’s disease in the tropics of today and in mankind’s 
early African setting. A large amount of research has been conducted on the effects of the Vitamin D hormone, 
1,25-dihydroxy vitamin D3, and its possible benefits on autoimmune diseases. Through this, it has been found that 
the Vitamin D hormone decreases the Th1-driven immune response in autoimmune diseases.2 This decrease of 
Th1 cytokines ceases inflammation in those afflicted with Crohn’s disease. It would therefore be logical to believe 
that an environment with a large amount of sunlight and Vitamin D could potentially be beneficial to an individual 
with the gene mutations characteristic of those with Crohn’s disease.  
Genetic Mutation
An interesting gene mutation carried by those suffering from Crohn’s disease is an alteration involving a Vitamin 
D receptor.4 This may make an individual carrying the mutations require greater amounts of Vitamin D for opti-
mal health.2 Imagine an individual in our evolutionary past with the Vitamin D receptor gene alterations. The only 
possible way for the harmful inflammatory effects of Crohn’s disease not to be seen in this individual would be if 
he or she were relegated to an environment with a large amount of Vitamin D. 
This is what could have potentially occurred in Africa. The individual acquired the plentiful mutations of Crohn’s 
disease but the harmful inflammatory effects of the disease were not present because the individual obtained a 
large amount of Vitamin D that suppressed overactive Th1 cytokine production. The potentially harmful genes 
found in those with Crohn’s disease may have been tolerated in this Vitamin D abundant environment.
Selection
An alternative hypothesis to explain the success of the Crohn’s disease phenotype is that it was selected for because 
it conferred greater reproductive success. As stated above, research has shown that a Vitamin D hormone may 
decrease the levels of Th1 cytokines in the body.2  Since Th1 cytokines are vitally important for fighting infection, a 
substantial decrease in the number of Th1 cytokines, due to the Vitamin D hormone, could possibly have negative 
effects on any individuals exposed to large amounts of Vitamin D.7  
It is therefore plausible to believe that Crohn’s disease and its elevated Th1 levels may have been selected for to in-
crease the ability of individuals in high Vitamin D concentrated areas to fight infection. An optimal Th1 cytokine 
level may have been reached in this highly concentrated Vitamin D environment with the acquisition of Crohn’s 
disease. Crohn’s disease mainly affects individuals during the prime years of reproductive success.8  This fact makes 
the idea of Crohn’s disease selection for fighting off infection and in return increasing reproductive success some-
what logical. Selection would not occur on the Crohn’s disease phenotype if it did not benefit or hinder the repro-
ductive success of the individual during these prime reproductive years. Selection occurs for reproductive success 
and Crohn’s disease may have been selected for to increase an individual’s ability to fight infection and thus be 
more efficient at passing on his or her genes. 
An individual may face an interesting tradeoff during the selection of Crohn’s disease.  The symptoms of Crohn’s 
disease are usually less than beneficial, but in the right environment (one filled with large amounts of Vitamin D 
and Helminthic worms) the symptoms may not be as severe and Crohn’s disease may be a tradeoff selected to fight 
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infection. The odds of dying from a mild form of Crohn’s disease could potentially be far less than the odds of dy-
ing from contracting a deadly infection. This could be regarded as a tradeoff for reproductive success. The idea of 
Crohn’s disease protecting against infection and increasing reproductive success could potentially mean that many 
more individuals contain the genetic mutations of Crohn’s disease than were once thought. If sufficient numbers of 
the mutations found in Crohn’s disease are not found in many diverse human populations, my hypothesis may be 
incorrect. New research into the potential benefits of Crohn’s and the prevalence of gene mutations in the popula-
tion must be performed.
The genetic mutations of Crohn’s disease may have been prevalent in our early evolutionary surroundings (Africa) 
and eventually through migration moved to an entirely new environment (Europe). Europe is an environment 
without the abundant Vitamin D or Helminthic worms of Africa. This new novel environment of Europe has the 
potential to negatively affect those that carry the Crohn’s disease genes.
Changing Environment
The new environment of Europe offers far less sunlight than the African environment.  This characteristic property 
of Europe is most likely beneficial to many with genes lacking the mutation because they are exposed to far less 
sun and thus less deadly melanoma but individuals carrying the Crohn’s disease mutations are negatively affected 
by the decrease in sunlight exposure. Crohn’s disease patients are already at a selective disadvantage because their 
bodies make an excess amount of Th1 cytokines, which can destroy their own tissues, but now their potentially 
negative genotype is exacerbated in these new surroundings by a lack of Vitamin D, which could decrease their 
Th1 levels.2 Crohn’s genes were interacting with a novel environment and this contact potentially killed many in-
dividuals who held the mutated genes. 
Centuries ago, through the implication of improved living conditions, hygiene began to improve in the European 
continent. This fact appears to have been positive for the general population but not for the percentage of the 
population that harbored the Crohn’s disease gene mutations. This increased cleanliness further reduced the num-
ber of Helminthic worms and other parasites that Crohn’s patients were exposed to. Without the large amounts 
of Helminthic worms in their environment, individuals with Crohn’s disease no longer received the benefits of an 
elevated Th2 cytokine count.5 Their additional Th1 cytokines were then free to destroy their gastrointestinal tract 
through excess inflammation. 
Socioeconomic levels for individuals also seemed to play a role in the rise of Crohn’s disease in Europe and even-
tually America. The richer an individual becomes and the more hygienic his or her living conditions become, the 
greater the opportunity to contract Crohn’s disease.6 A clear social stratification has begun to emerge within Eu-
rope and the United States.  The poor are now far less likely to contract Crohn’s disease, and the rich are becoming 
ill with excess inflammation.6 
The new European and American environment once again began to shape the phenotype of Crohn’s individuals 
when, about 6000 years ago, dairying was initiated.  Lactase persistence began to be selected for with the expan-
sion of pastoralist activities. Lactose digestion capacity (LDC) was beginning to become prevalent in northern 
Europe and North America.  In current times, LDC is very uncommon in Africa and Asia.9  This pattern of LDC 
positively correlates to the pattern of prevalence of Crohn’s disease in these continents.  Crohn’s disease is very rare 
in Africa and Asia.6 This fact leads many to believe that the key antigen that may interact with the NOD2 mutation 
in Crohn’s patients and trigger a negative inflammatory process by the immune system is located in milk.10
Antigen Studies
The most sited antigen in studies involving Crohn’s patients is Mycobacterium avium Paratuberculosis (MAP). 
This bacterium causes a disease similar to Crohn’s in sheep and has been found in a high percentage of individuals 
infected with Crohn’s disease.11 Through co-evolution, the pathogen appears to have evolved to survive the pas-
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teurization of milk.10 An ability of the pathogen to evolve much faster than individuals with Crohn’s disease, gives 
the pathogen a clear advantage. The ability to survive the high temperature of pasteurization potentially means the 
bacterium could now be transmitted in our novel environment through milk, cheese, or yogurt.12  
In viewing the symptoms of Crohn’s disease one observes that diarrhea is prevalent in the manifestations of the 
disease.1 The existence of diarrhea as a Crohn’s disease symptom could be viewed in two ways. Diarrhea could be 
an evolved defense to expel MAP from the body or it may be present due to manipulation of the host by the bacte-
ria to form an efficient way of transportation for the pathogen. Interestingly, individuals infected with Crohn’s dis-
ease also experience the symptom of deficiency of iron.1 It may appear that the low iron count of Crohn’s patients 
is harmful to the patient and is a negative effect of the disease manifestation but this may not be so. Insufficient 
iron may be present in Crohn’s individuals because iron is needed by bacteria to grow and multiply.13 By the body 
decreasing the amount of available iron in its tissues, it may in fact be creating an environment less than suitable 
for a multiplying pathogen.  Two perceived negative symptoms of Crohn’s disease can now be explained as defense 
mechanisms in the presence of the MAP bacterium. 
With the discovery of Mycobacterium avium Paratuberculosis, the evolutionary constraint of breastfeeding in 
mammals now presents a problem for individuals that carry the Crohn’s disease genes. Research has shown that 
breast milk can transmit MAP.10 It has also been observed that breastfeeding is correlated with higher instances of 
Crohn’s disease.14 This circumstance creates an interesting tradeoff and constraint for those who could potentially 
be vulnerable to contracting Crohn’s disease. Breastfeeding has many positive benefits to the immune system and 
other functions of the body but if breastfeeding passes on a bacterium that may trigger a severe inflammatory re-
sponse by the immune system, then the negative aspects of breastfeeding may outweigh its positive aspects.   
The evidence that MAP causes the trigger that initiates the excess inflammatory response of Crohn’s disease is 
controversial because recovering the bacterium from samples and individuals involves many complex chemi-
cal processes.12 This fact makes the research of this pathogen’s relevance in the pathogenesis of Crohn’s disease 
arduous and inconclusive. Better techniques for the recovery of the bacteria are needed but the relation between 
Mycobacterium avium Paratuberculosis, the evolution of lactose digestion, the use of milk, and Crohn’s disease is 
undoubtedly interesting.
Relationship with HIV
The fascinating aspects of the evolutionary history of Crohn’s disease continue when one investigates the effect 
HIV has on individuals affected by Crohn’s disease. When an individual contracts HIV, his or her Crohn’s disease 
mysteriously goes into remission.15 This phenomenon is most likely due to that fact that HIV causes a decrease 
in the patient’s immune system response. Without the excessive immune response and inflammatory processes, 
Crohn’s disease is nothing more than unexpressed genetic mutations. The relationship of Crohn’s disease to HIV 
offers an interesting but unlikely tradeoff. Although acquiring HIV stymies the symptoms of Crohn’s disease, it is 
much more in the individual’s benefit to show the effects of Crohn’s disease rather than HIV. HIV is much more 
deadly than Crohn’s disease and this fact makes this tradeoff improbable. The relationship between HIV and 
Crohn’s disease is remarkable.  It proves the complexities of the interactions between genetic mutations, environ-
ment, and the immune system in creating a very severe disease. 
Conclusion
The hypotheses presented throughout this paper must be thoroughly tested. The research into Crohn’s disease must 
now include the prevalence of the Crohn’s genetic mutations in the general population. A better understanding 
of their prevalence would create improved insight into their potential toleration in an early evolutionary environ-
ment. More research must be performed on how Vitamin D and its specific hormone, 1,25-dihydroxy vitamin D3, 
affect the immune system in not only individuals suffering from Crohn’s disease but in every individual. A clear 
understanding of the immunity of the body and its correlation to Crohn’s disease is crucial since the Th1 and Th2 
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cytokine imbalance is imperative in the manifestation of the disease.  Finally, studies into the effects of antibiotics 
and drugs specifically targeting Mycobacterium avium Paratuberculosis must be performed. The idea of bacterium 
or pathogens causing Crohn’s disease is controversial and studies into antibiotics would be greatly advantageous.    
The evolutionary history of Crohn’s disease is multifaceted and fascinating. It involves potential toleration of gene 
mutations due to an early environment that leveled out the Th1 and Th2 cytokines through Helminthic worms 
and sunlight. 
The journey continues into a new environment, Europe, where the gene mutations were no longer tolerated and 
became hazardous. The negative aspects of the genes may have multiplied when they experienced gene flow into 
new cultures that exposed the genes to a new bacterium presented in milk. A new exposure to bacterium creates 
unforeseen defense mechanisms and co-evolution between host and pathogen. Now in a new novel environment 
the complex nature of Crohn’s disease is shown through the constraint and tradeoffs of breastfeeding, the inter-
esting effects of AIDS on Crohn’s disease, and social stratification of the disorder. The journey of Crohn’s disease 
through our history has been extraordinary and deadly. A better understanding of the past and present mecha-
nisms of Crohn’s disease may have the potential to save lives.  
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